Skip to main content
All lobbying filings

ML Strategies, LLC

ML Strategies, LLC filed a Q1 report for Johnson & Johnson Services, Inc. on April 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Johnson & Johnson Services, Inc. · ​Medical device manufacturer

As filed: ML STRATEGIES, LLC for JOHNSON & JOHNSON SERVICES, INC.

All filings by ML Strategies, LLC · Everything Johnson & Johnson Services, Inc. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues related to cardiovascular health; H.R.5343 / S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025; issues related to Heart Recovery Awareness Day and H. Res. 1301, designating February 20th Heart Recovery Awareness Day

 Bills named in this filing 3
  • H.R. 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S. 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • H. Res. 1301
    Expressing support for the inaugural Heart Recovery Awareness Day on February 20, 2025.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem